Proof of leadership

Already live where
the market is going.

Not projections — production. The evidence a buying committee, a QA organization, or a regulator can check for themselves.

ePI by PharmaLedger 应用已上线的国家

自 2023 年起

ePI 应用提供已批准信息所用的语言

创始制药、技术、学术与患者合作伙伴

12 家全球制药企业

统一的开放标准：GS1 Digital Link、EU DPP、EPCIS 2.0

正在网络上运行

Documented publicly

ISPE Pharma 4.0 Baseline Case Study No. 237

The ePI implementation journey — proof-of-concepts, TRL 7 assessment, 300+ validation users, and the April 2023 production launch — is published through ISPE, not just claimed here.

Read the case study →Regulated environments

Compliance you can inspect, not just cite

GxP-aware platform, 21 CFR Part 11 posture, tamper-evident audit trail — with the live platform status published openly in the Trust Center.

Open the Trust Center →Standards-led

Built on the standards the market is converging on

GS1 Digital Link, EPCIS 2.0, the EU Digital Product Passport, and ePI on HL7 FHIR — implemented in production, connected to your existing systems rather than replacing them.

Explore the standards →Enterprise qualification

Supplier-qualified for regulated pharma

Enterprise qualification proof is available for approved sales conversations.

Request a consultation →

See it yourself

Every major claim here links to a source: production evidence, association governance, status history, architecture reference, or a controlled document.

Bring your QA lead, your architect, or your regulatory team. 30 minutes, no procurement, no NDA.

Book a consultation →